New Proposed Agency Would Merge Military with Medicine:
A “new” proposal by the Biden administration to create a health-focused federal agency modeled after DARPA is not what it appears to be. Promoted as a way to “end cancer,” this resuscitated “health DARPA” conceals a dangerous agenda.
"Last Wednesday, President Biden was widely praised in mainstream and health-care–focused media for his call to create a “new biomedical research agency” modeled after the US military’s “high-risk, high-reward” Defense Advanced Research Projects Agency, or DARPA. As touted by the president, the agency would seek to develop “innovative” and “breakthrough” treatments for cancer, Alzheimer’s disease, and diabetes, with a call to “end cancer as we know it.”
Far from “ending cancer” in the way most Americans might envision it, the proposed agency would merge “national security” with “health security” in such as way as to use both physical and mental health “warning signs” to prevent outbreaks of disease or violence before they occur. Such a system is a recipe for a technocratic “pre-crime” organization with the potential to criminalize both mental and physical illness as well as “wrongthink.”
The Biden administration has asked Congress for $6.5 billion to fund the agency, which would be largely guided by Biden’s recently confirmed top science adviser, Eric Lander. Lander, formerly the head of the Silicon Valley–dominated Broad Institute, has been controversial for his ties to eugenicist and child sex trafficker Jeffrey Epstein and his relatively recent praise for James Watson, an overtly racist eugenicist. Despite that, Lander is set to be confirmed by the Senate and Congress and is reportedly significantly enthusiastic about the proposed new “health DARPA.”
US Sending Potentially Contaminated Vaccines Around Globe, Emergent Biosolutions Sued by Investors
Emergent Biosolution contaminated up to 70 million doses of Johnson & Johnson Covid-19 vaccination with active ingredient of AstraZeneca vaccinations. The factory has never received approval to FDA approval for production of either Johnson & Johnson or AstraZeneca ingredients.
"Quality-control problems at a Baltimore plant manufacturing Covid-19 vaccines have led health officials on three continents to pause the distribution of millions of Johnson & Johnson doses, as the troubles of a politically connected U.S. contractor ripple across the world . Doses made at the plant owned by Emergent BioSolutions have not been cleared by the Food and Drug Administration for use in the United States, and the Biden administration has repeatedly assured Americans that none of the Johnson & Johnson shots administered domestically were made there.
But millions of doses have been shipped abroad, including to Canada, the European Union and South Africa. Regulators in various countries are now working to ensure that those doses are safe after the disclosure in March that workers at the Baltimore plant accidentally contaminated a batch of Johnson & Johnson’s vaccine with the harmless virus used to manufacture AstraZeneca’s. Both vaccines were produced at the same site. The mistake forced Emergent to throw out up to 15 million Johnson & Johnson doses after tests showed that the batch failed to meet purity requirements".
Shockingly, officials are weighing whether to administer potentially contaminated doses:
"There is now a discussion among regulators about balancing the need to save lives with the risk of using the questioned doses, even as it remains unclear what, if any, health consequences there would be".
Johnson & Johnson Covid-19 vaccinations were found to have a 66% efficacy rate of symptom reduction while inducing side effects in many cases similar to attributed Covid-19 infections 55% of the time.
Biden has announced he will donate AstraZeneca vaccinations to other nations, a gesture that loses its charitable intent with the realization the drug has high safety risk issues, and Denmark discontinued the use of the drug entirely due to blood clotting issues:
AstraZeneca is now under investigation for inducing rare neurological disorders, in addition to the blood clotting clotting concerns with the controversial adenovirus technology drug.
"Europe's medicines regulator said on Friday it was reviewing reports of a rare nerve-degenerating disorder in people who have received AstraZeneca's Covid-19 vaccine, and requested more detailed data on the cases from the company".
EU Regulators also announced in the Friday night news dump, investigations are occurring into both Moderana & Pfizer covid-19 mRNA vaccinations for potential cardiovascular injury. Recent global reports have found numerous cases of myocarditis associated with the new mRNA technology drugs:
"As part of a regular review of safety reports for the vaccine, Vaxzevria, the European Medicines Agency's safety committee is analysing data provided on cases of Guillain-Barre syndrome, the regulator said.
The EMA is also looking into reports of heart inflammation with Pfizer-BioNTech's vaccine, called Comirnaty, and Moderna's shot, it said. Both the vaccines use new mRNA technology to build immunity against the coronavirus".
Israel recent study into the issue found a direct correlation between myocarditis and the Pfizer Covid-19 vaccination in young men under 30 describing the connection as 'likely'. The report only came to light after it was leaked to the press:
"The physicians emphasized that a further study is needed also to confirm a link between the vaccine and the heart problems, but according to Channel 12 they described it as “likely” in the report".
For a full report on Myocarditis and Covid-19 vaccines please refer here:
For the latest data on Covid-19 VAERS data, refer here: